-
Why metal prices are soaring to record highs
-
Stocks tepid in thin pre-Christmas trade
-
UN experts slam US blockade on Venezuela
-
Bethlehem celebrates first festive Christmas since Gaza war
-
Set-piece weakness costing Liverpool dear, says Slot
-
Two police killed in explosion in Moscow
-
EU 'strongly condemns' US sanctions against five Europeans
-
Arsenal's Kepa Arrizabalaga eager for more League Cup heroics against Che;sea
-
Thailand-Cambodia border talks proceed after venue row
-
Kosovo, Serbia 'need to normalise' relations: Kosovo PM to AFP
-
Newcastle boss Howe takes no comfort from recent Man Utd record
-
Frank warns squad to be 'grown-up' as Spurs players get Christmas Day off
-
Rome pushes Meta to allow other AIs on WhatsApp
-
Black box recovered from Libyan general's crashed plane
-
Festive lights, security tight for Christmas in Damascus
-
Zelensky reveals US-Ukraine plan to end Russian war, key questions remain
-
El Salvador defends mega-prison key to Trump deportations
-
Stranger Things set for final bow: five things to know
-
Grief, trauma weigh on survivors of catastrophic Hong Kong fire
-
Asian markets mixed after US growth data fuels Wall St record
-
Stokes says England player welfare his main priority
-
Australia's Lyon determined to bounce back after surgery
-
Stokes says England players' welfare his main priority
-
North Korean POWs in Ukraine seeking 'new life' in South
-
Japanese golf star 'Jumbo' Ozaki dies aged 78
-
Johnson, Castle shine as Spurs rout Thunder
-
Thai border clashes hit tourism at Cambodia's Angkor temples
-
From predator to plate: Japan bear crisis sparks culinary craze
-
Asian markets mostly up after US growth fuels Wall St record
-
'Happy milestone': Pakistan's historic brewery cheers export licence
-
Chevron: the only foreign oil company left in Venezuela
-
US denies visas to EU ex-commissioner, four others over tech rules
-
Dynamite Blockchain Delivers Record Q3 2025
-
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
-
SMX's Integrated Value Proposition: One System, Many Markets, Compounding Leverage
-
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
-
Alta Copper Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders and Optionholders to be Held on January 26, 2026
-
Pantheon Resources PLC Announces TR-1: Notification of Major Holdings
-
Bridgeline Expands Footprint with Closeout Retailer Choosing HawkSearch for Its On-Site Search Experience and Personalization
-
Koepka leaves LIV Golf: official
-
US slams China policies on chips but will delay tariffs to 2027
-
Arsenal reach League Cup semis with shoot-out win over Palace
-
Contenders Senegal, Nigeria start Cup of Nations campaigns with wins
-
Tunisia ease past Uganda to win Cup of Nations opener
-
S&P 500 surges to record after strong US economic report
-
UK police say no action against Bob Vylan duo over Israel army chant
-
Libya's top military chief killed in plane crash in Turkey
-
Venezuela passes law to jail backers of US oil blockade
-
French parliament passes emergency budget extension
Climate change, population growth threats as malaria fight stalls
The fight against malaria has stalled after two decades of progress, with climate change and population growth among factors threatening a resurgence of the potentially fatal disease, campaigners said Tuesday.
Insufficient funding for increasingly costly prevention programmes risked efforts against the mosquito-borne illness at a cost of hundreds of thousands of lives and billions of dollars, they said.
The impact would be most keenly felt in Africa which accounts for 95 percent of cases of the disease that claimed 590,000 deaths worldwide in 2023, the African Leaders Malaria Alliance (ALMA) and Malaria No More UK said in a new report.
Several African countries had reported upsurges in cases between January and June 2025 after heavy rainfalls, they said.
Malaria mortality has halved over the past two decades, said the report released ahead of a November 21 meeting in South Africa to secure contributions to the Global Fund to Fight AIDS, TB and Malaria, which covers 59 percent of malaria spending.
"Insufficient funding, however, has caused malaria progress to stall," it said.
"A perfect storm of climate change, rising drug and insecticide resistance, trade disruptions, and global insecurity further undermine the efficacy of malaria interventions."
There were around 263 million cases of malaria globally in 2023, an increase of 11 million cases from the previous year, according to the UN's World Malaria Report 2024.
- Spreading -
"Increases in temperature and flooding due to climate change have increased the number of mosquito breeding sites," ALMA executive secretary Joy Phumaphi told AFP.
In Rwanda, for example, these sites now existed at higher altitudes than previously, she said in an interview.
The malaria-carrying Anopheles stephensi mosquito from Asia has meanwhile spread into Africa while insecticide resistance has increased, she said.
New-generation prevention methods, such as dual-insecticide mosquito nets and the use of drones to disperse chemicals that kill mosquito larva, were effective but also more costly, she said.
At the same time, Africa's population had almost doubled in the past 30 years. "It's more expensive, but we also have to cover a bigger population than before," Phumaphi said.
Malaria -- most prevalent in Nigeria -- is a leading cause of worker and student absenteeism, and also causes learning and cognitive disruption in children.
Besides saving lives, ridding countries of the disease would have "massive" returns on economies, including by boosting productivity and tourism, Phumaphi said.
Malaria "leads to huge amounts of out-of-pocket payments for households and is a major cause of poverty," she said. "Once this market is protected, their purchasing power is enormous."
An anti-malaria vaccine in use in 23 African countries was around 40 percent effective and had to be accompanied by other prevention measures. But a new vaccine undergoing human trials was hoped to show 80 percent efficacy, she said.
Funding modelling showed that a halt in all prevention interventions could cost Africa $83 billion in lost GDP by 2030, alongside 525 million additional cases and 990,000 more deaths on top of the already high annual toll, the report said.
L.Harper--AMWN